title: Cyclic AMP-dependent modulation of vesicular monoamine transport in pheochromocytoma cells.
abstract: Cyclic AMP (cAMP) is well known to enhance tyrosine hydroxylase activity in PC12 cells. We were able to demonstrate, however, that the cellular dopamine level in PC12 was lowered by dibutyryl cAMP. Furthermore, the decrease in the cellular level of dopamine was accompanied by about a 10-fold increase in the medium. The aim of this work was to elucidate the effect of cAMP on catecholamine transport. Dibutyryl cAMP did not induce exocytotic release of norepinephrine but rather inhibited its uptake. As with forskolin and cholera toxin, physiological signaling molecules such as vasoactive intestinal polypeptide (VIP) and AMP, for which PC12 cells are known to have receptors linked to activation of adenylate cyclase, also inhibited norepinephrine uptake. The inhibitory effects of dibutyryl cAMP, VIP, and AMP were dose dependent, and EC50 values were estimated to be 100 microM, 10 nM, and 1.0 microM, respectively. The inhibition profile of dibutyryl cAMP over the time course of norepinephrine uptake was biphasic: inhibition became clearly detectable after the cytosolic pool of norepinephrine had been saturated. This profile is similar to that of reserpine. Nomifensine, however, inhibited uptake at a rather constant rate throughout the entire time course. The ATP-dependent serotonin uptake by digitonin-permeabilized cells was lowered to approximately 50% that of the control by dibutyryl cAMP treatment before permeabilization, indicating inhibition of vesicular monoamine transport. This effect was also dependent on a dibutyryl cAMP concentration with an EC50 of < or = 100 microM.(ABSTRACT TRUNCATED AT 250 WORDS)
authors: Department of Biochemistry, Meikai University School of Dentistry, Saitama, Japan.
authors: N
authors: N
authors: Nakanishi
authors: S
authors: S
authors: Onozawa
authors: R
authors: R
authors: Matsumoto
authors: H
authors: H
authors: Hasegawa
authors: S
authors: S
authors: Yamada
mesh_terms: D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D001692:Biological Transport; D003994:Bucladesine / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects; D000242:Cyclic AMP / Q000502:physiology*; D004072:Digitonin / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D005089:Exocytosis; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics; D016716:PC12 Cells; D051381:Rats; D013997:Time Factors
chemical_list: D015306:Biogenic Monoamines; D002395:Catecholamines; D003994:Bucladesine; D000242:Cyclic AMP; D004072:Digitonin; D004298:Dopamine; D009638:Norepinephrine